HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat Hodgkin's lymphoma?
Disease control Recruiting nowThis study tests a combination of two drugs, azacitidine and pembrolizumab, in people whose Hodgkin's lymphoma has returned or not responded to treatment. The goal is to see if the combo can shrink tumors. About 24 adults will take part at one center.
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New study tracks how cancer treatment impacts Women's fertility and sexual health
Knowledge-focused Recruiting nowThis study follows 475 women with breast cancer or lymphoma to understand how cancer treatments affect their sexual health, fertility, and ability to have children. Participants complete questionnaires and may optionally provide blood samples to measure ovarian function. The goal…
Matched conditions: HODGKIN'S LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC